Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody
Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.
Our latest content
Check out what's new in our company !
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.